Rallybio Corp

Ownership Transactions Reported by 20 Insiders

Symbol
RLYB on Nasdaq
Industry
Pharmaceutical Preparations
Location
234 Church Street, Suite 1020, New Haven, CT

There are no Buy or Sell transactions made by insiders since 12/31/2023

Rallybio Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Opportunities I, L.P. 10%+ Owner $30.6M Jun 3, 2022
5AM Partners V, LLC 10%+ Owner $29.8M Mar 7, 2023
5AM Ventures V, L.P. 10%+ Owner $22.8M Jul 29, 2021
Fmr Llc Other* $13.9M Aug 2, 2021
Jeffrey M. Fryer Chief Financial Officer & Treasurer $386K Mar 21, 2022
Stephen Uden Chief Executive Officer, Director $382K Feb 15, 2024
Martin Mackay Executive Chairman, Director $382K Feb 15, 2024
Jonathan I. Lieber Chief Financial Officer $253K Feb 15, 2024
Steven Ryder Chief Medical Officer $212K Feb 15, 2024
Paula Soteropoulos Director $29.2K May 15, 2024
Helen M. Boudreau Director $29.2K May 15, 2024
Robert Hopfner Director $29.2K May 15, 2024
Christine A. Nash Director $29.2K May 15, 2024
Hui Liu Director $29.2K May 15, 2024
Wendy Chung Director $29.2K May 15, 2024
Ronald Hunt Director $29.2K May 15, 2024
Kush Parmar Director $29.2K May 15, 2024
Timothy M. Shannon Director $10.7K Jan 3, 2022
Lucian Iancovici Director Jul 29, 2021
Viking Global Investors Lp 10%+ Owner Nov 15, 2022

Recent Insider Transactions by Companies or Individuals for Rallybio Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.